Pulse Biosciences Inc expected to post a loss of 49  cents a share - Earnings Preview

Pulse Biosciences

07/05/2021 12:25

* Pulse Biosciences Inc  PLSE.OQ   PLSE.O  is expected to show a
no change in quarterly revenue when it reports results on May
10 .
​* Refinitiv's mean analyst estimate for Pulse Biosciences Inc
is for a loss of 49 cents per share. For the same quarter last
year, the company reported a loss of 57 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Pulse
Biosciences Inc is $43​, about 59.7% above​ its last closing
price of $17.33. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.45       -0.45      -0.54     Missed  -20
 Sep. 30 2020  -0.44       -0.44      -0.51     Missed  -15.9
 Jun. 30 2020  -0.50       -0.50      -0.53     Missed  -6​
 Mar. 31 2020  -0.47       -0.47      -0.57     Missed  -21.3
 Dec.          ​           -0.61      -0.66     Missed  -8.2​
 31​ 2019​                                              
 Sep. 30 2019  -0.61       -0.61      -0.57     Beat    6.6​
 Jun. 30 2019  -0.51       -0.51      -0.55     Missed  -7.8
 Mar. 31 2019  -0.44       -0.44      -0.49     Missed  -11.4
 This summary was machine generated May 7 at 11:25 GMT.  All
figures in US dollars unless otherwise stated